Form 4: Teladoc Health COO Michael Waters Reports Stock Transactions

Teladoc Health's Chief Operating Officer, Michael Willem Waters, reported the acquisition and disposal of company stock, including the sale of shares to cover tax obligations related to vesting restricted stock units.

Summary

• Michael Willem Waters, the Chief Operating Officer of Teladoc Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On August 1, 2024, Waters acquired 11,319 shares of common stock through the vesting of restricted stock units.
• Also on August 1, 2024, Waters disposed of 11,319 restricted stock units.
• On August 2, 2024, Waters sold 6,053 shares of common stock at a price of $8.142 per share.
• The sale was to cover tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, Waters directly owns 74,214 shares of Teladoc Health common stock.
• Waters also directly owns 45,280 restricted stock units.
• The restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
• The restricted stock units were granted on August 1, 2022, and vest over time.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about the executive's holdings.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a key executive.

Key Dates